Malignant Kidney Neoplasm — Trials

Malignant Kidney Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,142 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 453
Recruiting: 233
Ph III recruiting: 18
Growth YoY: +3.1%
Industry share: 29%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.2%
Trials / 1,000 deaths: 30.7 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (339)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07488572	Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study	enrolling by invitation	Phase 2	60	Sun Yat-sen UniversityOTHER	1	Mar 23, 2026	clinicaltrials
NCT07101900	68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses	enrolling by invitation	Phase 2	100	Peking Union Medical College HospitalOTHER	1